Med Biogene Stock Market Value
| MBGNF Stock | USD 0.01 0.00 0.00% |
| Symbol | Med |
Med BioGene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Med BioGene's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Med BioGene.
| 11/23/2025 |
| 02/21/2026 |
If you would invest 0.00 in Med BioGene on November 23, 2025 and sell it all today you would earn a total of 0.00 from holding Med BioGene or generate 0.0% return on investment in Med BioGene over 90 days. Med BioGene is related to or competes with Guided Therapeutics, Nova Leap, and Izotropic. Previously, it was engaged in the life science business with a focus on the development and commercialization of genomic... More
Med BioGene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Med BioGene's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Med BioGene upside and downside potential and time the market with a certain degree of confidence.
Med BioGene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Med BioGene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Med BioGene's standard deviation. In reality, there are many statistical measures that can use Med BioGene historical prices to predict the future Med BioGene's volatility.Med BioGene Backtested Returns
We have found three technical indicators for Med BioGene, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Med BioGene are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Med BioGene has perfect predictability. Overlapping area represents the amount of predictability between Med BioGene time series from 23rd of November 2025 to 7th of January 2026 and 7th of January 2026 to 21st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Med BioGene price movement. The serial correlation of 1.0 indicates that 100.0% of current Med BioGene price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Med Pink Sheet
Med BioGene financial ratios help investors to determine whether Med Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Med with respect to the benefits of owning Med BioGene security.